![]() Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | ||
Founding Date | Founding Date 2001 | Founding Date 1916 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Kunming, CN HQ | Locations Parkville, AU HQ King Of Prussia, US |
Employees | Employees 2,388 | Employees 32,698 |
Valuation ($) | Valuation ($) 3.3 b | Valuation ($) 95.1 b |
Financial | ||
Revenue (est.) | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) $15.4b (FY, 2025) |
Cost of goods | Cost of goods ¥615.2m (FY, 2025) | Cost of goods $6.5b (FY, 2025) |
Gross profit | Gross profit ¥1.8b (FY, 2025) | Gross profit $9.1b (FY, 2025) |
Net income | Net income ¥125.2m (FY, 2025) | Net income $3.1b (FY, 2025) |
CSL is a biotech company providing life-saving medicines.
View company